Price $30.14 |
Market Cap
3.12B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
18.2
|
P/B
3.09
|
P/S
0.47
|
Dividend %
3.40%
|
|
P/CF
60.5
|
P/FCF
-
|
Op. Cash Flow
-679.5K
|
FCF
-8.1
|
|
Op. Margin
-7.00%
|
Net Margin
-7.70%
|
ROE
-52.90%
|
ROI
10.30%
|
|
ROA
-17.40%
|
EPS Growth
17.90%
|
Current Ratio
1.5
|
Debt/Equity
50.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Assertio Holdings Inc (ASRT) | $0.90 | - | - | 48.5M | Strong Buy |
| Recro Pharma Inc (REPH) | $2.10 | - | - | 114M | Strong Buy |
| Rigel Pharmaceuticals, Inc. (RIGL) | $3.71 | - | - | 709M | Strong Buy |
| Endo International PLC (ENDP) | $2.76 | - | - | 499.7M | Strong Buy |
| Sensus Healthcare Inc (SRTS) | $3.54 | - | - | 60.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
